Clinical trial
SAPIEN 3 China Post Market Registry Study
NCT05168826 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SAPIEN 3 China Post Market Registry Study
- Lead sponsor
- Edwards Lifesciences
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- January 24, 2022
- Completion date
- December 31, 2035
- Enrollment
- 250 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.
aortic stenosis, severe